Biopharmaceutical Assessment of Mesh Aerosolised Plasminogen, a Step towards ARDS Treatment
Acute respiratory distress syndrome (ARDS) is a severe complication of lung injuries, commonly associated with bacterial, fungal and viral infections, including SARS-CoV-2 viral infections. ARDS is strongly correlated with patient mortality and its clinical management is very complex, with no effect...
Main Authors: | Lucia Vizzoni, Chiara Migone, Brunella Grassiri, Ylenia Zambito, Baldassare Ferro, Paolo Roncucci, Filippo Mori, Alfonso Salvatore, Ester Ascione, Roberto Crea, Semih Esin, Giovanna Batoni, Anna Maria Piras |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/6/1618 |
Similar Items
-
Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics
by: Anna Maria Piras, et al.
Published: (2020-11-01) -
Broadness and specificity: ArdB, ArdA, and Ocr against various restriction-modification systems
by: Anna A. Kudryavtseva, et al.
Published: (2023-04-01) -
Effects of methyl prednisolone in early ARDS
by: Nasef Abdelsalam Rezk, et al.
Published: (2013-01-01) -
Factors associated with oxygenation improvement in children with ARDS
by: Abdul Chairy, et al.
Published: (2014-02-01) -
Observational case-control study of non-invasive ventilation in patients with ARDS
by: G. Domenighetti, et al.
Published: (2016-01-01)